A non-invasive imaging tool could test potential cancer therapies quickly to personalize therapy for patients.

A new analysis of published studies found that FDG-PET technology is less accurate in diagnosing lung cancer versus benign disease in regions where infections like histoplasmosis or tuberculosis are common.

Joe B. (Bill) Putnam Jr., M.D., Ingram Professor of Cancer Research and chair of the Department of Thoracic Surgery, and colleague Felix Fernandez, M.D., assistant professor of Surgery, Emory University School of Medicine, Atlanta, have received a grant to investigate the most effective forms of surgery to treat lung cancer patients.

The Nashville Predators Foundation recently presented a $318,242 check to Monroe Carell Jr. Children’s Hospital at Vanderbilt for the 365 Pediatric Cancer Fund.

Soldiers deployed to tropical and sunny climates are coming home with increased risk factors for a threat far from the battlefield: skin cancer.

A Vanderbilt lung cancer patient’s exceptional response to different types of therapies spurred research that suggests lung cancer patients with specific gene alterations may benefit from combination therapy that targets two different cancer pathways.

A subpopulation of bone cancer cells may be responsible for driving clinically aggressive behavior, suggesting new treatment options.